<p>Confocal microscopy was used to determine the localization of WT- vs. Q1069R-ACE mutant expressed in CHO cells following immunostaining with anti-ACE mAb 9B9 and Alexa 488 goat anti-mouse secondary Ab. A-C: WT-ACE expressing cells; D-F: Q1069R-ACE expressing cells. A,B and D,E. Immunostaining of WT and Q1069R ACE in 0.3% paraformaldehye for 15 min at 4C (fixed only). B and E. Treatment with the chemical chaperone sodium butyrate and proteosome inhibitor MG132 for 24 hrs followed by immunostaining with 9B9 mAb. C and F. CHO cells fixed and permeabilized with 3% paraformaldehyde for 15 min at 37C and labeled as above show WT-ACE on the plasma membrane and to a lesser extent in the cytosol and Q1069R-ACE in perinuclear areas.</p
<p>The localization of Gln1069 in the C-domain of human ACE which was mutated to Arg is shown using ...
<p>HEK293 cells expressing FLAP and expressing either the 5-LO1-W102A mutant or the 5-LO∆13-W102A mu...
<p>Representative immunoblot for ACE2 treated without (−) or with (+) deglycosylation with PNGase F ...
<p>(A) Schematic diagram of wt-ACE, Cyt-del-ACE, Extra-del-ACE, and S<sup>1270</sup>A-ACE. (B) Analy...
<p><b>A–D.</b> Precipitation of ACE activity from cell lysates (membrane-bound form) and culture med...
<p>Cell ELISA assay was performed on CHO cells expressing WT and mutant (Y465D) ACE using the panel ...
<p>Membrane-bound WT and mutant ACE lysates were normalized to achieve 5 mU/ml ACE activity with Z-P...
<p><b>A</b>. ACE activity of the membrane-bound form of ACE of CHO cells (lysates) stably expressing...
<p>Membrane-bound (<b>A</b>) and soluble (<b>B</b>) mutant ACE (Q1069R) were pre-incubated with N-do...
<p>CHO cells were transiently transfected with plasmids coding for wild-type (WT) and mutant (Q1069R...
<p>CHO cells were transiently transfected with plasmids coding for wild-type (WT) and mutant (S333W)...
<p><b>A.</b> The lysates and culture medium of HEK cells expressing WT and mutant (Y465D) ACE (norma...
<p>(A) Representative immunoblot for ACE2 protein in concentrated media (Lanes 1–3) and cell lysates...
<p>ACE activity of the membrane-bound form of ACE in lysates of CHO cells expressing WT and mutant A...
<p>(<b>A</b>) Visualization of subcellular localization of p97 in AX2 wild-type cells with polyclona...
<p>The localization of Gln1069 in the C-domain of human ACE which was mutated to Arg is shown using ...
<p>HEK293 cells expressing FLAP and expressing either the 5-LO1-W102A mutant or the 5-LO∆13-W102A mu...
<p>Representative immunoblot for ACE2 treated without (−) or with (+) deglycosylation with PNGase F ...
<p>(A) Schematic diagram of wt-ACE, Cyt-del-ACE, Extra-del-ACE, and S<sup>1270</sup>A-ACE. (B) Analy...
<p><b>A–D.</b> Precipitation of ACE activity from cell lysates (membrane-bound form) and culture med...
<p>Cell ELISA assay was performed on CHO cells expressing WT and mutant (Y465D) ACE using the panel ...
<p>Membrane-bound WT and mutant ACE lysates were normalized to achieve 5 mU/ml ACE activity with Z-P...
<p><b>A</b>. ACE activity of the membrane-bound form of ACE of CHO cells (lysates) stably expressing...
<p>Membrane-bound (<b>A</b>) and soluble (<b>B</b>) mutant ACE (Q1069R) were pre-incubated with N-do...
<p>CHO cells were transiently transfected with plasmids coding for wild-type (WT) and mutant (Q1069R...
<p>CHO cells were transiently transfected with plasmids coding for wild-type (WT) and mutant (S333W)...
<p><b>A.</b> The lysates and culture medium of HEK cells expressing WT and mutant (Y465D) ACE (norma...
<p>(A) Representative immunoblot for ACE2 protein in concentrated media (Lanes 1–3) and cell lysates...
<p>ACE activity of the membrane-bound form of ACE in lysates of CHO cells expressing WT and mutant A...
<p>(<b>A</b>) Visualization of subcellular localization of p97 in AX2 wild-type cells with polyclona...
<p>The localization of Gln1069 in the C-domain of human ACE which was mutated to Arg is shown using ...
<p>HEK293 cells expressing FLAP and expressing either the 5-LO1-W102A mutant or the 5-LO∆13-W102A mu...
<p>Representative immunoblot for ACE2 treated without (−) or with (+) deglycosylation with PNGase F ...